Boosting Productivity for Advanced Biomanufacturing by Re-Using Viable Cells

Monoclonal antibodies (mAb) have gained enormous therapeutic application during the last decade as highly efficient and flexible tools for the treatment of various diseases. Despite this success, there remain opportunities to drive down the manufacturing costs of antibody-based therapies through cos...

Descripción completa

Detalles Bibliográficos
Autores principales: Reger, Lucas Nik, Saballus, Martin, Matuszczyk, Jens, Kampmann, Markus, Wijffels, Rene H., Martens, Dirk E., Niemann, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978186/
https://www.ncbi.nlm.nih.gov/pubmed/36873352
http://dx.doi.org/10.3389/fbioe.2023.1106292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978186/
https://www.ncbi.nlm.nih.gov/pubmed/36873352
http://dx.doi.org/10.3389/fbioe.2023.1106292

Ejemplares similares